Enhancing participation in cardiac rehabilitation: Focus on underserved populations

Philip A Ades1, Sherrie Khadanga1, Patrick D Savage1

  • 1Department of Medicine, Division of Cardiology, University of Vermont Larner College of Medicine, Cardiac Rehabilitation and Prevention, Burlington, VT, United States of America.

Insights

Cardiac rehabilitation (CR) improves outcomes but has low participation, especially in underrepresented groups. Strategies like automated referrals and CR liaisons can boost engagement and secondary prevention.

Area of Science:

  • Cardiology
  • Public Health
  • Rehabilitation Medicine

Background:

  • Cardiac rehabilitation (CR) is crucial for reducing morbidity and mortality post-cardiac events.
  • Current CR participation and adherence rates remain suboptimal.
  • Underrepresented populations, including women, minorities, and lower socioeconomic groups, show particularly low engagement.

Purpose of the Study:

  • To review current CR participation rates and successful interventions.
  • To examine interventions for improving CR engagement in underrepresented populations.
  • To explore necessary changes in CR programs to serve more eligible individuals.

Main Methods:

  • Literature review of CR participation rates.
  • Analysis of interventions aimed at increasing CR enrollment and adherence.
  • Examination of strategies tailored for underrepresented groups.
  • Exploration of program expansion and alternative models.

Main Results:

  • Automated referral systems and CR liaison personnel are effective interventions for increasing participation.
  • Specific strategies are needed to improve CR engagement in underserved populations.
  • A multifaceted approach combining center-based, tele-based, and community-based programs is likely necessary.

Conclusions:

  • Improving CR participation requires addressing barriers in underrepresented groups.
  • Enhanced referral processes and dedicated support staff are key.
  • Expanding CR accessibility through diverse delivery models is essential for maximizing secondary prevention.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
56
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
47
Restorative Care01:19

Restorative Care

Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
79
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
56
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
66